Glenmark Pharmaceuticals has informed that it has enclosed press release on 29th April 2020 titled ‘Glenmark Pharmaceuticals receives ANDA tentative approval for Dapagliflozin and Saxagliptin Tablets, 10 mg/5 mg’.
The above information is a part of company’s filings submitted to BSE.